Skip to main content
Premium Trial:

Request an Annual Quote

Sema4: Sema4 Elements

Sema4, a molecular diagnostics and clinical data company, has launched Sema4 Elements, a portfolio of genomic tests, digital tools, and services in reproductive health for patients and providers. It includes a new version of the company's Expanded Carrier Screen (ECS) that provides personalized residual risk assessments, its noninvasive prenatal test (NIPT), and its Natalis newborn screen. One of the digital tools in the portfolio is Pregnancy Journey, an educational resource and tracking tool for pregnant women. Services include customized workflows, genetic counseling, and patient-friendly billing policies.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.